Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease (original) (raw)
References
Apelt J, Kumar A, Schliebs R (2002) Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res 953:17–30 ArticlePubMedCAS Google Scholar
Bardgett ME, Boeckman R, Krochmal D, Fernando H, Ahrens R, Csernansky JG (2003) NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Res Bull 60:131–142 ArticlePubMedCAS Google Scholar
Bartolini M, Bertucci C, Vavrini V, Andrisano V (2003) Beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65:407–416 ArticlePubMedCAS Google Scholar
Beach TG, Kuo Y, Schwab C, Walker D, Roher A (2001) Reduction of cortical amyloid levels in guinea pig brain after systemic administration of physostigmine. Neurosci Lett 310:21–24 ArticlePubMedCAS Google Scholar
Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M (2002) Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 22:3234–3243 PubMedCAS Google Scholar
Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2:271–276 ArticlePubMedCAS Google Scholar
Csernansky J, Bargett M, Dong H, Humphrey W, Wang L (2002) Hippocampal structure and the action of cholinomimetic drugs. Drug Dev Res 51:1–10 Google Scholar
Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E (2003) Inhibition of human cholinesterase by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord 17:117–126 ArticlePubMedCAS Google Scholar
Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, The Tacrine Collaborative Study Group (1992) A double-blind placebo-controlled multicenter study of tacrine for Alzheimer’s disease. N Engl J Med 327:1253–1259 ArticlePubMedCAS Google Scholar
Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127:601–609 ArticlePubMedCAS Google Scholar
Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137–147 ArticlePubMedCAS Google Scholar
Fodero LR, Saez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH (2002) Altered glycosylation of acetylcholinesterse in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J Neurochem 81:441–448 ArticlePubMedCAS Google Scholar
Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer’s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100:10417–10422 ArticlePubMedCAS Google Scholar
Guntern E, Bouras C, Hoff PR, Vallet PG (1992) An improved thioflavine S method for staining neurofibrillary tangles ad senile plaques in Alzheimer’s disease. Experientia 48:8–10 ArticlePubMedCAS Google Scholar
Hsiao K (2001) Learning and memory in transgenic mice modeling Alzheimer’s disease. Learn Mem 8:301–308 ArticlePubMed Google Scholar
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274:99–102 ArticlePubMedCAS Google Scholar
Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme. Neuron 16:881–891 ArticlePubMedCAS Google Scholar
Irizarry M, McNamara M, Fedorchak K, Hsiao K, Hyman B (1997) APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965–973 ArticlePubMedCAS Google Scholar
Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ (2001) Neuropathology of mice carrying mutant APP(swe) and/or PS1 (M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Exp Neurol 170:227–243 ArticlePubMedCAS Google Scholar
Liu L, Ikonen S, Tapiola T, Tanila H, Van Groen T (2002) Fimbria–fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice. Exp Neurol 177:565–574 ArticlePubMedCAS Google Scholar
Mazzucchelli M, Porrello E, Villetti G, Pietra C, Govoni S, Racchi M (2003) Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells. J Neural Transm 110:935–947 ArticlePubMedCAS Google Scholar
Moghul S, Wilkinson D (2001) Use of acetylcholinesterase inhibitors in Alzheimer’s disease. Expert Rev Neurotherapeutics 1:61–69 ArticleCAS Google Scholar
Mullan M (2000) Genetic contributions to causes of Alzheimer’s disease: current perspectives and future directions, pp 307–309. In: New insights into genetics and pathophysiology of Alzheimer’s disease: what are the clinical and therapeutic implications? J Clin Psychiatry 61:307–315 ArticlePubMed Google Scholar
Nilsberth C, Basun H, Eckman C, Lannfelt L, Younkin S (2002) Plasma levels of Aβ42 and Aβ40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine. Dement Geriatr Cogn Disord 14:156–160 ArticlePubMed Google Scholar
Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304–307 ArticlePubMedCAS Google Scholar
Pakaski M, Kasa P (2003) Role of acetycholinesterase inhibitors in the metabolism of amyloid precursor protein. Curr Drug Target CNS Neurol Disord 2:163–171 ArticleCAS Google Scholar
Piazzi L, Rampa A, Bisi A, Gobbi S, Belluti F, Cavalli A, Bartolini M, Andrisano V, Valenti P, Recanatini M (2003) 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2_H_-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer’s disease therapy. J Med Chem 46(12):2279–2282 ArticlePubMedCAS Google Scholar
Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging 24:777–787 ArticlePubMedCAS Google Scholar
Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology 50:136–145 PubMedCAS Google Scholar
Shigeta M, Homma A (2001) Donepezil for Alzheimer’s disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev 7:353–368 ArticlePubMedCAS Google Scholar
Storch A, Schrattenholz A, Cooper JC, Abdel Ghani EM, Gutbrod O, Weber KH, Reinhardt S, Lobron C, Hermsen B, Soskic V et al (1995) Physostigmine, galanthamine and codeine act as noncompetitive nicotinic agonists on clonal rat pheochromocytoma cells. Eur J Pharmacol 290:207–219 ArticlePubMedCAS Google Scholar
Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94(24):13287–13292 ArticlePubMedCAS Google Scholar
Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C, Galatamine USA-10 Study Group (2000) A 5-month, randomized placebo-controlled trial of galantamine in AD. Neurology 54:2269–2276 PubMedCAS Google Scholar
West M, Gundersen H (1990) Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296:1–22 ArticlePubMedCAS Google Scholar
Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci 22:1858–1867 PubMedCAS Google Scholar